Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
2016 1
2017 1
2019 1
2020 2
2021 4
2022 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease.
Hiatt WR, Fowkes FG, Heizer G, Berger JS, Baumgartner I, Held P, Katona BG, Mahaffey KW, Norgren L, Jones WS, Blomster J, Millegård M, Reist C, Patel MR; EUCLID Trial Steering Committee and Investigators. Hiatt WR, et al. N Engl J Med. 2017 Jan 5;376(1):32-40. doi: 10.1056/NEJMoa1611688. Epub 2016 Nov 13. N Engl J Med. 2017. PMID: 27959717 Free article. Clinical Trial.
Gender Differences in Non-Persistence with Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers among Older Hypertensive Patients with Peripheral Arterial Disease.
Wawruch M, Murin J, Tesar T, Paduchova M, Petrova M, Celovska D, Havelkova B, Trnka M, Masarykova L, Alfian SD, Aarnio E. Wawruch M, et al. Among authors: paduchova m. Biomedicines. 2022 Jun 22;10(7):1479. doi: 10.3390/biomedicines10071479. Biomedicines. 2022. PMID: 35884784 Free PMC article.
Unprovoked or provoked venous thromboembolism: not the prevalent criterion to decide on anticoagulation extension in clinical practice of various countries-the prospective, international, observational WHITE study.
Palareti G, Bignamini A, Cini M, Li YJ, Urbanek T, Madaric J, Bouslama K, Sokurenko GY, Andreozzi GM, Matuška J, Mansilha A, Barinov V; WHITE study group. Palareti G, et al. Intern Emerg Med. 2022 Jan;17(1):71-82. doi: 10.1007/s11739-021-02765-1. Epub 2021 Jul 27. Intern Emerg Med. 2022. PMID: 34313959 Free PMC article.
Reinitiation and Subsequent Discontinuation of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers among New and Prevalent Users Aged 65 Years or More with Peripheral Arterial Disease.
Wawruch M, Murin J, Tesar T, Petrova M, Paduchova M, Celovska D, Havelkova B, Trnka M, Masarykova L, Alfian SD, Aarnio E. Wawruch M, et al. Among authors: paduchova m. Biomedicines. 2023 Jan 26;11(2):368. doi: 10.3390/biomedicines11020368. Biomedicines. 2023. PMID: 36830904 Free PMC article.
Factors associated with non-adherence to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in older patients with peripheral arterial disease.
Wawruch M, Petrova M, Tesar T, Murin J, Schnorrerova P, Paduchova M, Celovska D, Havelkova B, Trnka M, Alfian SD, Aarnio E. Wawruch M, et al. Among authors: paduchova m. Front Pharmacol. 2023 Aug 10;14:1199669. doi: 10.3389/fphar.2023.1199669. eCollection 2023. Front Pharmacol. 2023. PMID: 37637425 Free PMC article.
12 results